Drug Development for Prostate Cancer with Biochemical Recurrence: Trials and Tribulations

Eur Urol Oncol. 2021 Aug;4(4):553-557. doi: 10.1016/j.euo.2021.05.009. Epub 2021 Jun 18.

Authors

Nicolas Sayegh¹, Neeraj Agarwal¹, Umang Swami²

Affiliations

¹ Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
² Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. Electronic address: [email protected].

PMID: 34148857
DOI: 10.1016/j.euo.2021.05.009

No abstract available

Publication types

Editorial
Comment

MeSH terms

Drug Development
Humans
Male
Prostate-Specific Antigen
Prostatic Neoplasms* / drug therapy

Substances

Prostate-Specific Antigen